Real World Evidence (RWE) can be enabled by evaluating Real World Data (RWD).
What we have to offer:
Effectiveness studies, real world data (RWD) gathering, evidence creation, and sophisticated health economic modelling are among the advanced analytical and Health Economics and Outcomes Research (HEOR) consulting services offered.
Medical affairs and HEOR executives from pharmaceutical, biotech, and medical device firms are invited to attend.
Why is it significant:
We deliver in the following ways: Process:
Our team of health economists has considerable experience with RWD modelling, which eliminates ambiguity and allows for data-driven decisions. To develop RWE from primary and secondary real-world patient data, we combine deep domain experience, mature procedures, and proprietary NLP/ML clinical and statistical algorithms.
Our multidisciplinary team of physicians, medical writers, data scientists, and statisticians helps healthcare organisations measure the impact of pharmaceutical goods on patient quality of life, as well as HCP knowledge and attitudes regarding them.
In addition to NLP-enabled literature reviews and Meta-Analysis/Network Meta-Analysis for systematic comparative effectiveness studies, clinical trial design, and scientific writing, our HEOR service portfolio includes NLP-enabled literature reviews and Meta-Analysis/Network Meta-Analysis for systematic comparative effectiveness studies, clinical trial design, and scientific writing.
